THE FOLLOW-UP OF PATIENTS WITH SURGICAL SOLITARY KIDNEY - THE UNDER-ESTIMATED ROLE OF COMORBIDITIES

Authors

  • C. PRICOP “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • D. PUIA “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • I. CHIRIAC “Dr. C. I. Parhon” Clinical Hospital, Iasi, Romania
  • Adelina MIRON “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

In order to customize the follow-up plan and lower the risks of end-stage renal disease progression (ESRD), we set out to create a monitoring program for patients with surgical solitary kidneys. Additionally, by determining the underlying etiology and comorbidities (such as pre-existing CKD or Diabetes). 91 patients have been found who satisfy the inclusion requirements. Material and methods: There were 51 ladies and 40 guys among them. They ranged in age from 20 to 90. The average age was 60.69 years (SD +/- 15.87). There was no difference in the mean age between the genders (63.22 vs. 58.71, p=0.08). Kidney cancer (50.54%), upper urothelial tract carcinoma (25.27%), pyonephrosis (17.58%), and kidney trauma (6.59%) were the primary pathologies for which surgery was performed. The patients were also arbitrarily separated into three age groups: Group A, 20-40 years old; Group B, 41-60 years old; and Group C, over 60 years old. Results: One month after discharge, C-reactive protein increased (p=0.05), and eGFR decreased significantly (p=0.003). The most common comorbidity (74.72%; n=68) was arterial hypertension. Of these, 51.47% (n=35) have diabetes mellitus concurrently. Diabetes was the second-highest occurrence, with 49.45% (n=45) of patients receiving therapy for it. Also, at the time of surgery, 12.08 % (n=11) had CKD, according to KDIGO definition. Since acquired solitary kidney patients are more likely to experience rapidly declining renal function, they require continuous monitoring. Conclusions: Younger individuals are more prone to develop CKD slowly. Therefore, the clinician has to monitor issues like kidney stones or urinary tract infections.

Author Biographies

  • C. PRICOP, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Surgery (II)

  • D. PUIA, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Surgery (II)

  • I. CHIRIAC, “Dr. C. I. Parhon” Clinical Hospital, Iasi, Romania

    Clinic of Urology and Kidney Transplantation

  • Adelina MIRON, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Surgery (II)

References

1. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985; 249(3Pt 2): F324-337.
2. Sanna-Cherchi S, Ravani P, Corbani V, et al. Renal outcome in patients with congenital anomalies of the kidney and urinary tract. Kidney Int 2009; 76(5): 528-533.
3. Kim S, Chang Y, Lee YR, et al. Solitary kidney and risk of chronic kidney disease. Eur J Epidemiol 2019; 34(9): 879-888.
4. Groen In’t Woud S, Roeleveld N, Westland R, et al. Uncovering risk factors for kidney injury in children with a solitary functioning kidney. Kidney Int 2023; 103(1): 156-165.
5. Argueso LR, Ritchey ML, Boyle ET Jr, Milliner DS, Bergstralh EJ, Kramer SA. Prognosis of patients with unilateral renal agenesis. Pediatr Nephrol 1992; 6(5): 412-416.
6. Xu Q, Wu H, Zhou L, et al. The clinical characteristics of Chinese patients with unilateral renal agen-esis. Clin Exp Nephrol 2019; 23(6): 792-798.
7. Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 2003; 64(6): 2204-2213.
8. Pricop C, Ivănuţă M, Stan A, et al. Correlations between stones composition, dietary and comorbidities context of the lithiasic patient. Rom J Morphol Embryol 2020; 61(4): 1227-1233.
9. Kiberd M, Panek R, Kiberd BA New onset diabetes mellitus post-kidney transplantation. Clinical Transplantation 2006; 20(5): 634-639.
10. Alfandary H, Haskin O, Goldberg O, et al. Is the prognosis of congenital single functioning kidney benign? A population-based study. Pediatr Nephrol 2021; 36(9): 2837-2845.
11. Ellis RJ. Chronic kidney disease after nephrectomy: a clinically-significant entity? Transl Androl Urol 2019; 8(Suppl 2): S166-S174.
12. Pricop C, Ivănuta M, Puia D. Active metabolic lithiasis: A condition that requires proper evaluation and monitoring. Exp Ther Med 2022; 24(6): 715.
13. Puia D, Radavoi GD, Proca TM, Puia A, Jinga V, Pricop C. Urinary tract infections in complicated kidney stones: Can they be correlated with Guy's stone score? J Pak Med Assoc 2022; 72(9): 1721-1725.
14. Pricop C, Puia D, Mereuta O, et al. Infected hydronephrosis: can we reduce patient suffering and costs? J Pak Med Assoc 2016; 66(11): 1372-1377.
15. Naqvi SB, Collins AJ. Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 2006; 13(3): 199-204.
16. Shang W, Li L, Ren Y, et al. History of kidney stones and risk of chronic kidney disease: a meta-analysis. Peer J 2017; 5: e2907.
17. Demirjian S, Lane BR, Derweesh IH, et al. Chronic kidney disease due to surgical removal of neph-rons: relative rates of progression and survival. J Urol 2014; 192: 1057-1062.
18. Kidney Disease: Improving Global Outcomes CKD Workgroup. KDIGO 2012 clinical practice guide-line for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3:1-150.

Additional Files

Published

2023-09-30